Why is olfactory neuroepithelium?

Huang, 2020, Clinical neurorestorative cell therapies: Developmental process, current state, and future prospective, J Neurorestoratol, 8, 61, 10.26599/JNR.2020.9040009 Huang, 2021, Clinical neurorestorative cell therapies for stroke, Prog Brain Res, 265, 231, 10.1016/bs.pbr.2021.06.006 Wang, 2021, A pilot study of clinical cell therapy for patients with vascular dementia, J Neurorestoratol, 9, 137, 10.26599/JNR.2021.9040011 Wang, 2020, Olfactory ensheathing cells in chronic ischemic stroke: A phase 2 double- blind, randomized, controlled trial, J Neurorestoratol, 8, 182, 10.26599/JNR.2020.9040019 Min, 2020, Potentiation of cord blood cell therapy with erythropoietin for children with CP: a 2 × 2 factorial randomized placebo-controlled trial, Stem Cell Res Ther, 11, 509, 10.1186/s13287-020-02020-y Petrou, 2020, Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis, Brain, 143, 3574, 10.1093/brain/awaa333 Jaillard, 2020, Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial, Transl Stroke Res, 11, 910, 10.1007/s12975-020-00787-z Chung, 2021, Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke, Neurology, 96, e1012, 10.1212/WNL.0000000000011440 Berry, 2019, NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results, Neurology, 93, e2294, 10.1212/WNL.0000000000008620 Kawabori, 2021, Cell therapy for chronic TBI: interim analysis of the randomized controlled STEMTRA trial, Neurology, 10.1212/WNL.0000000000011450 Galipeau, 2016, International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials, Cytotherapy, 18, 151, 10.1016/j.jcyt.2015.11.008 Holbrook, 2011, Immunohistochemical characterization of human olfactory tissue, Laryngoscope, 121, 1687, 10.1002/lary.21856 Durante, 2020, Single-cell analysis of olfactory neurogenesis and differentiation in adult humans, Nat Neurosci, 23, 323, 10.1038/s41593-020-0587-9 Hahn, 2005, In vivo and in vitro neurogenesis in human olfactory epithelium, J Comp Neurol, 483, 154, 10.1002/cne.20424 Murrell, 2005, Multipotent stem cells from adult olfactory mucosa, Dev Dyn, 233, 496, 10.1002/dvdy.20360 Huang, 2002, Preliminary report of clinical trial for olfactory ensheathing cell transplantation treating the spinal cord injury, J Nav Gen Hosp PLA, 15, 18 Huang, 2003, Influence of patients’ age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury, Chin Med J (Engl), 116, 1488 Guest, 2006, Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb- derived cells, Spinal Cord, 44, 135, 10.1038/sj.sc.3101820 Huang, 2006, Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury (in Chinese), Chin J Reparative Reconstr Surg, 20, 434 Zhang, 2006, Treatment of thoracic spine and spinal cord injury (in Chinese), Chin J Rehab Theor Pract, 12, 336 Zheng, 2007, Olfactory ensheathing cell transplantation in 106 patients with old spinal cord injury: Differences in ages, sexes, disease courses, injured types and sites, Neural Regen Res, 2, 380, 10.1016/S1673-5374(07)60071-1 Huang, 2006, Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury: A 38-month follow-up with MRI (in Chinese), Chin J Reparative Reconstr Surg, 20, 439 Huang, 2012, Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury, Cell Transplant, 21, S23, 10.3727/096368912X633734 Bao, 2007, Olfactory ensheathing cell transplantation in the treatment of spinal cord injury in 5 cases, J Clin Rehab Tiss Eng Res, 11, 512 Liu, 2008, Neurofunctional evaluation in spinal cord injury patients after olfactory ensheathing cell transplantation, J Clin RehabTiss Eng Res, 12, 3037 Zheng, 2008, Influence of transplanting time on olfactory ensheathing cell transplantation for spinal cord injury, J Clin Rehab Tiss Eng Res, 12, 583 Wu, 2012, Clinical observation of fetal olfactory ensheathing glia transplantation (OEGT) in patients with complete chronic spinal cord injury, Cell Transplant, 21, S33, 10.3727/096368912X633743 Wang, 2013, Five years follow-up observation on patients with spinal cord injury treated with olfactory ensheathing cell transplantation, J Invest Med, 61, S5 Rao, 2013, Long-term outcome of olfactory ensheathing cell transplantation in six patients with chronic complete spinal cord injury, Cell Transplant, 22, S21, 10.3727/096368913X672127 Rao, 2013, Clinical application of olfactory ensheathing cells in the treatment of spinal cord injury, J Int Med Res, 41, 473, 10.1177/0300060513476426 Tabakow, 2013, Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury, Cell Transplant, 22, 1591, 10.3727/096368912X663532 Tabakow, 2014, Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging, Cell Transplant, 23, 1631, 10.3727/096368914X685131 Zheng, 2013, Olfactory ensheathing cell transplantation improves sympathetic skin responses in chronic spinal cord injury, Neural Regen Res, 8, 2849 Féron, 2005, Autologous olfactory ensheathing cell transplantation in human spinal cord injury, Brain, 128, 2951, 10.1093/brain/awh657 Mackay-Sim, 2008, Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial, Brain, 131, 2376, 10.1093/brain/awn173 Chen, 2018, Comparison of intramedullary transplantation of olfactory ensheathing cell for patients with chronic complete spinal cord injury worldwide, J Neurorestoratol, 6, 146, 10.26599/JNR.2018.9040012 Lima, 2006, Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study, J Spinal Cord Med, 29, 191, 10.1080/10790268.2006.11753874 Lima, 2010, Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury, Neurorehabil Neural Repair, 24, 10, 10.1177/1545968309347685 Chhabra, 2009, Autologous olfactory mucosal transplant in chronic spinal cord injury: an Indian pilot study, Spinal Cord, 47, 887, 10.1038/sc.2009.54 Wang, 2016, Autologous olfactory lamina propria transplantation for chronic spinal cord injury: three-year follow-up outcomes from a prospective double-blinded clinical trial, Cell Transplant, 25, 141, 10.3727/096368915X688065 Dlouhy, 2014, Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report, J Neurosurg Spine, 21, 618, 10.3171/2014.5.SPINE13992 Williamson, 2021, Autograft- derived spinal cord mass in the cervical spine following transplantation with olfactory mucosa cells for traumatic spinal cord injury: case report, J Neurosurg Spine, 34, 254, 10.3171/2020.6.SPINE20251 Huang, 2009, Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients (in Chinese), Chin J Reparative Reconstr Surg, 23, 14 Rabinovich, 2005, Cell therapy of brain stroke, Bull Exp Biol Med, 139, 126, 10.1007/s10517-005-0229-y Chen, 2013, Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke, Cell Transplant, 22, S83, 10.3727/096368913X672154 Guo, 2019, Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review, J Neurorestoratol, 7, 82, 10.26599/JNR.2019.9040009 Seledtsov, 2005, Cell therapy of cerebral palsy, Bull Exp Biol Med, 139, 499, 10.1007/s10517-005-0330-2 Chen, 2010, Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial, Cell Transplant, 19, 185, 10.3727/096368910X492652 Seledtsov, 2005, Cell transplantation therapy in re-animating severely head-injured patients, Biomed Pharmacother, 59, 415, 10.1016/j.biopha.2005.01.012 Seledtsov, 2006, Immunological and clinical aspects of cell therapy in the treatment of aftereffects of craniocerebral injury, Bull Exp Biol Med, 141, 121, 10.1007/s10517-006-0110-7 Seledtsov, 2006, Cell therapy of comatose states, Bull Exp Biol Med, 142, 129, 10.1007/s10517-006-0310-1 Chen, 2007, Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis (in Chinese), Chin J Reparative Reconstr Surg, 21, 961 Huang, 2008, Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study, Clin Transplant, 22, 710, 10.1111/j.1399-0012.2008.00865.x Chen, 2012, Olfactory ensheathing cell neurorestorotherapy for amyotrophic lateral sclerosis patients: benefits from multiple transplantations, Cell Transplant, 21, S65, 10.3727/096368912X633789 Xi, 2013, Preliminary report of multiple cell therapy for patients with multiple system atrophy, Cell Transplant, 22, S93, 10.3727/096368913X672145 Xi, 2016, Cell-based neurorestorative therapy for postpoliomyelitis syndrome: a case report, J Neurorestoratol, 4, 45, 10.2147/JN.S98584 Rabinovich, 2003, Transplantation treatment of spinal cord injury patients, Biomed Pharmacother, 57, 428, 10.1016/j.biopha.2003.05.001 Seledtsova, 2010, Delayed results of transplantation of fetal neurogenic tissue in patients with consequences of spinal cord trauma, Bull Exp Biol Med, 149, 530, 10.1007/s10517-010-0985-1 Zamani, 2021, Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial, Spinal Cord Chen, 2014, A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries, Cell Transplant, 23, S35, 10.3727/096368914X685014 Zhang, 2017, Olfactory ensheathing cell transplantation for a patient with chronic sciatic nerve injury, J Neurorestoratol, 5, 1, 10.2147/JN.S120524 Lamond, 2015, Olfactory ensheathing cell in Neurorestoratology Ramón-Cueto, 1994, Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants, Exp Neurol, 127, 232, 10.1006/exnr.1994.1099 Li, 2011, Olfactory ensheathing cell transplantation into spinal cord prolongs the survival of mutant SOD1G93A ALS rats through neuroprotection and remyelination, Anat Rec, 294, 847, 10.1002/ar.21362 Li, 2013, Intracranial transplant of olfactory ensheathing cells can protect both upper and lower motor neurons in amyotrophic lateral sclerosis, Cell Transplant, 22, S51, 10.3727/096368913X672208 Khankan, 2016, Olfactory ensheathing cell transplantation after a complete spinal cord transection mediates neuroprotective and immunomodulatory mechanisms to facilitate regeneration, J Neurosci, 36, 6269, 10.1523/JNEUROSCI.0085-16.2016 Liu, 2018, Neuroprotective effect of olfactory ensheathing cells co-transfected with Nurr1 and Ngn2 in both in vitro and in vivo models of Parkinson's disease, Life Sci, 194, 168, 10.1016/j.lfs.2017.12.038 Augestad, 2017, Effects of neural stem cell and olfactory ensheathing cell co-transplants on tissue remodelling after transient focal cerebral ischemia in the adult rat, Neurochem Res, 42, 1599, 10.1007/s11064-016-2098-3 Ramón-Cueto, 2000, Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia, Neuron, 25, 425, 10.1016/S0896-6273(00)80905-8 López-Vales, 2006, Acute and delayed transplantation of olfactory ensheathing cells promote partial recovery after complete transection of the spinal cord, Neurobiol Dis, 21, 57, 10.1016/j.nbd.2005.06.011 López-Vales, 2007, Chronic transplantation of olfactory ensheathing cells promotes partial recovery after complete spinal cord transection in the rat, Glia, 55, 303, 10.1002/glia.20457 Ziegler, 2011, Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection, Exp Neurol, 229, 109, 10.1016/j.expneurol.2011.01.007 Takeoka, 2011, Axon regeneration can facilitate or suppress hindlimb function after olfactory ensheathing glia transplantation, J Neurosci, 31, 4298, 10.1523/JNEUROSCI.4967-10.2011 Ramer, 2004, Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury, J Comp Neurol, 473, 1, 10.1002/cne.20049 Lankford, 2008, Olfactory ensheathing cells exhibit unique migratory, phagocytic, and myelinating properties in the X-irradiated spinal cord not shared by Schwann cells, Glia, 56, 1664, 10.1002/glia.20718 Azimi Alamouti, 2015, Remyelination of the corpus callosum by olfactory ensheathing cell in an experimental model of multiple sclerosis, Acta Med Iran, 53, 533 Ardiles, 2007, Response of olfactory axons to loss of synaptic targets in the adult mouse, Exp Neurol, 207, 275, 10.1016/j.expneurol.2007.06.022 Huang, 2011, RhoA-ROCK- Myosin pathway regulates morphological plasticity of cultured olfactory ensheathing cells, Exp Cell Res, 317, 2823, 10.1016/j.yexcr.2011.09.004 Takeoka, 2010, Noradrenergic innervation of the rat spinal cord caudal to a complete spinal cord transection: effects of olfactory ensheathing glia, Exp Neurol, 222, 59, 10.1016/j.expneurol.2009.12.008 López-Vales, 2004, Transplanted olfactory ensheathing cells modulate the inflammatory response in the injured spinal cord, Neuron Glia Biol, 1, 201, 10.1017/S1740925X05000037 Xie, 2019, Olfactory ensheathing cells grafted into the retina of rcs rats suppress inflammation by down-regulating the JAK/STAT pathway, Front Cell Neurosci, 13, 341, 10.3389/fncel.2019.00341 Harris, 2009, Olfactory ensheathing cells: nitric oxide production and innate immunity, Glia, 57, 1848, 10.1002/glia.20899 Cao, 2010, Diffusible, membrane- bound, and extracellular matrix factors from olfactory ensheathing cells have different effects on the self- renewing and differentiating properties of neural stem cells, Brain Res, 1359, 56, 10.1016/j.brainres.2010.08.063 Lu, 2017, Differentiation of human olfactory mucosa mesenchymal stem cells into photoreceptor cells in vitro, Int J Ophthalmol, 10, 1504 Alizadeh, 2019, Differentiation of human olfactory system-derived stem cells into dopaminergic neuron-like cells: A comparison between olfactory bulb and mucosa as two sources of stem cells, J Cell Biochem, 120, 19712, 10.1002/jcb.29277 Alizadeh, 2019, Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs, J Chem Neuroanat, 96, 126, 10.1016/j.jchemneu.2019.01.003 Alizadeh, 2019, Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease, Neurosci Lett, 696, 52, 10.1016/j.neulet.2018.12.011 Simorgh, 2019, Olfactory mucosa stem cells: An available candidate for the treatment of the Parkinson's disease, J Cell Physiol, 234, 23763, 10.1002/jcp.28944 Simorgh, 2021, Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease, Neurotox Res, 39, 598, 10.1007/s12640-020-00290-1 Stamegna, 2018, Grafts of olfactory stem cells restore breathing and motor functions after rat spinal cord injury, J Neurotrauma, 35, 1765, 10.1089/neu.2017.5383 Bonnet, 2020, Immediate or delayed transplantation of a vein conduit filled with nasal olfactory stem cells improves locomotion and axogenesis in rats after a peroneal nerve loss of substance, Int J Mol Sci, 21, 10.3390/ijms21082670